Navigation Links
AXA Equitable Makes it Easier to Stop Ignoring Life Insurance
Date:11/5/2007

Company Introduces Simplified Issue Underwriting for Return of Premium Term

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- To make the purchase of life insurance easier and more convenient, AXA Equitable introduced today in approved states a simplified issue underwriting process for its Return of Premium Term (ROP Term(SM)) life insurance on policy face amounts from $100,000 to $249,999. "ROP Term with Simplified Issue makes buying life insurance easier and more convenient," said Claude Methot, Senior Vice President and Chief Product Officer, who made today's announcement. "There are no needles. No samples. No lengthy applications and complicated underwriting questionnaires. No paramed exams. No waiting for attending physician statements from your doctor." Instead, applying for ROP Term(SM) with Simplified Issue involves a painless, self-administered oral swab, a private 15 to 20 minute telephone interview, and a short application. Two underwriting classes are available - Simplified Issue Non-Tobacco User and Simplified Issue Tobacco User.

The Appeal of ROP Term(SM) - Protection and Refund Potential

AXA Equitable's ROP Term(SM) series offers level death protection for a selected period and the potential to receive a premium refund. If a policyholder outlives the ROP Term(SM) level premium period selected (20, 25 or 30 years) and the policy is still inforce, he or she will receive a refund of 100% of the eligible cumulative premiums paid*. The cash refunded is federal income tax free. "In essence," said Mr. Methot, "with ROP Term(SM) the policyholder gets the needed coverage during the level premium period, but if the insured lives beyond that period, she receives her money back. And now with simplified issue underwriting, we're making it easier to access these benefits."

Ease of Convertibility

As families and/or businesses grow, it may make sense to 'move up' to permanent life insurance, which offers lifelong death benefit protection. D
'/>"/>

SOURCE AXA Equitable
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
2. David Kahal Joins AXA Equitable as National Sales Manager
3. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism
4. New Smart Technology Makes Patient Data Collection Easier, More Efficient
5. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
6. Independence Blue Cross Makes Music for Members Ears
7. A Place for Mom COO Makes Seattles 40 Under 40 List
8. Sesame Street Exhibition Makes Texas Premier at The Health Museum
9. Study makes progress in zoning in on biomarkers for better colon cancer treatment
10. New Online Tool Makes Enrollment in Blue Cross of California Easier
11. 1-800-PACK-RAT Makes a Splash During Annual Walk for Hope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2008)...HAYWARD, Calif., Aug. 28 /PRNewswire/ -- Guava Tec...greement with Hudson Control Group to,provide drug...for cellular,analyses. This non-exclusive agreemen...ive by Guava Technologies. The initiative is a dir...ll analysis technology to,support higher throughpu...
(Date:8/28/2008)...very from brain injury, not injury itself, associa...Aug. 28 (HealthDay News) -- A group of researchers...brain that is thought to play a key role in Alzhei... known as amyloid beta, was directly linked to bra...r,s disease. When brain cell communication increas...
(Date:8/28/2008)... MessageSolution, Inc., the l...chiving for electronic discovery, litigation suppo...unced that MessageSolution Enterprise Email Archiv...oice Award for Exchange Archiving. Enterprise Ema...pports Microsoft Exchange server versions 5.5 thro...
(Date:8/28/2008)... The Accreditation Council fo... the Education Division of the College of American...th Commendation as a provider of continuing medica... Northfield, IL (PRWEB) August 28, 2008 -- The...ation (ACCME) has awarded the Education Division o...
Breaking Medicine News(10 mins):Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 2Health News:San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research 3Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 2Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 3Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 4Health News:MessageSolution Enterprise Email Archive™ Wins MSExchange.org Readers' Choice Award for Exchange Archiving 5Health News:College of American Pathologists' Education Division Receives Top Honor 2Health News:College of American Pathologists' Education Division Receives Top Honor 3
...inister for Health and Family Welfare, announced t...ore on the second phase of the Reproductive and Ch... announced this package at the 49th All India Cong...chi yesterday. He said that the challenge in front...
... be maintained by a low fat diet into old age, acc...ie counting is unnecessary. The study on nearly 50...in the medical journal, the Journal of the America...sion that reducing fat intake to under 20% of the ...
...as revealed that more devastating earthquakes are ...period of 50 years. // They will inflict far great...zaffarabad in Pakistan. Roger Bilham who has been...kistan for the past two months, said that a huge a...
...ult blood test (FOBT) is a simpler way of identify...researchers claim in an article published online i...BT is used to screen individuals who might be havi... substantially the number of false positives in a ...
Other Medicine News:Health News:More Severe Earthquakes May Hit Kashmir In Future 2
(Date:8/27/2008)..., from BLISS-52 trial, expected by mid-2009 - - D...by fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswi...aq: HGSI ) today announced it has completed enrol...f two pivotal Phase 3,randomized clinical trials o...ive systemic lupus erythematosus (SLE). Belimumab ...
(Date:8/26/2008)...ents can drive safely six weeks following surgical...SNewswire/ -- Six weeks following,bunion surgery, ...e able to,get back behind the wheel of a car again...e Journal of Bone and Joint Surgery ( http://www.j...sponse in patients who underwent a,first metatarsa...
(Date:8/26/2008)...ewswire/ -- Omeros Corporation today announced the... trial investigating,OMS103HP in arthroscopic ante...y. OMS103HP is an investigational drug product tha... is designed to improve postoperative,knee functio...patients an,earlier return to work. The article ti...
(Date:8/25/2008)...g. 25 /- Anthera Pharmaceuticals,Inc....oping,anti-inflammatory drugs, today announced the...coronary events with Near-term Cardiovascular,Infl...xamine the impact of,varespladib when administered...Syndrome (ACS) event., The FRANCIS trial is desig...
Breaking Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Shaking may cause brain damage and serious long term effects to infants 1376 1Shaking may cause brain damage and serious long term effects to infants 1376 2American College of Physicians publishes The Fenway Guide to LGBT Health 1374 1American College of Physicians publishes The Fenway Guide to LGBT Health 1374 2IMPACT initiative looks to improve patient participation in clinical trials 1372 1IMPACT initiative looks to improve patient participation in clinical trials 1372 2New genetic research into nicotine addiction shows promise for personalized treatment 421 1New genetic research into nicotine addiction shows promise for personalized treatment 421 2
...esented at ASCO with cediranib - a selective,VEGF ...ents alive,and progression- free at six months(1),...he,investigational agent cediranib (AZD2171) were ...can Society of Clinical Oncology,(ASCO) from a stu...an invasive form of brain tumor with a high unmet ...
...atients With Follicular Lymphoma Reported,Today at.../PRNewswire/ -- GlaxoSmithKline plc,announced toda... a,single one-week course of frontline treatment w... and Iodine I-131 Tositumomab) in,76 patients with...,lymphoma (NHL). This regimen was found to induce ...
Other Medicine Technology:Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens.
The Directigen™ Meningitis Individual Tests are presumptive latex slide agglutination tests for the direct qualitative detection of antigens to H. influenzae type b, S. pneumoniae, N. meningitid
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease).
The AP250 Auto Projector is a remote-controlled, programmable, random-access, high-resolution, ophthalmic projector.
Medicine Products: